Importantly, this study demonstrated the infiltration of human NKG2D-positive lymphocytes in tumor sections of treated mice, without severe pathological changes in vital organs, highlighting the safety and potential of NKG2D CAR-T cells as an immunotherapeutic strategy for human colorectal cancer. Here, KLRK1 is linked to colorectal cancer.